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The extracellular concentrations of dopamine (DA), dihydroxyphenylacetic acid (DOPAC), homovanil- 
lic acid (HVA), and 5-hydroxyindoleacetic acid (5-HIAA) in the striatum were measured by in vivo micro- 
dialysis in freely moving rats one week after the animals were treated with neurotoxic doses of methamphe- 
tamine. Methamphetamine produced a marked depletion of striatal DA measured in postmortem tissue, 
and in the extracellular concentrations of DOPAC, HVA and 5-HIAA. In contrast, the resting extracellu- 
lar concentration of DA in striatum was the same as in saline-pretreated controls. Furthermore, metham- 
phetamine-pretreated rats were able to increase their concentration of extracellular DA to the same extent 
as controls in response to a (+)-amphetamine challenge. It is suggested that this adaptive response is pro- 
bably responsible, at least in part, for the absence of obvious behavioral deficits in animals exposed to 
neurotoxic doses of methamphetamine. 
Repea ted  t r ea tment  with high doses o f  m e t h a m p h e t a m i n e  is toxic to d o p a m i n e  
(DA)  and  sero tonin  neurons  (see ref. 14 for review). F o r  example ,  it causes a long- 
last ing deple t ion  o f  s t r ia tal  D A ,  loss o f  D A  reup take  sites and  decrease in tyros ine  
hydroxylase  act ivi ty  [9, 10]; effects that  are  accompan ied  by degenera t ion  o f  s t r ia tal  
D A  terminals  [14]. Despi te  this long- las t ing neurona l  damage ,  m e t h a m p h e t a m i n e  
p re t r ea tmen t  does  not  p roduce  any o f  the deficits in spon taneous  behav io r  typical ly  
associa ted  with D A  deplet ion.  Ra ts  show normal  rates o f  milk  d r ink ing  [5, 7], and  
rhesus monkeys  show no rma l  eye t rack ing  funct ion and fine hand  coo rd ina t i on  
[3, 4]. 
Studies  in an imals  deple ted  o f  s t r ia tal  D A  with 6 - h y d r o x y d o p a m i n e  ( 6 - O H D A )  
have shown that  funct ions  are spared  fol lowing a par t ia l  6 - O H D A  lesion, p resuma-  
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bly because of presynaptic compensatory changes in the remaining terminals [15] that 
serve to maintain a relatively normal extracellular concentration of DA [t, 6, 13]. 
The most toxic doses of methamphetamine produce a persistent depletion of striatal 
DA by no more than about 80-85% [9, 14], and therefore, similar compensatory 
changes may be responsible for the sparing of function associated with neurotoxic 
methamphetarnine treatment. To test this hypothesis rats were given a series of neu- 
rotoxic doses of methamphetamine, and one week later the extracellular concentra- 
tion of DA in striatum was estimated by use of in vivo microdialysis. 
Male Holtzman rats were anesthetized and a stainless~steel guide cannula was 
placed stereotaxically on the dural surface above the corpus of the neostriatum. 
Approximately one week following surgery each animal received an injection of 15 
mg/kg of methamphetamine (s.c.), or saline, once every 6 h for a total of 5 injections; 
a treatment previously shown to produce a long-lasting depletion of striatal DA [9]. 
One week after the last injection each animal was lightly anesthetized with ether and 
a removable version of the dialysis probe described by Robinson and Whishaw [13] 
was inserted into the guide cannula and fixed in the location illustrated on Fig. 4 in 
Robinson and Whishaw [13]. Each animal was then put into a hemispherical test 
chamber and left undisturbed until the dialysis experiment began the next day. At 
least 3 samples of dialysate were collected under resting (baseline) conditions, and 
then each animal received a challenge injection of 1.5 mg/kg of (+)-amphetamine 
sulfate (weight of the salt; i.p.) and sample collection continued for 200 min. The ef- 
fect of (+)-amphetamine on motor behavior was also quantified. Each animal was 
decapitated a few days later and tissue obtained for neurochemical analysis. 
The dialysis probe and analytical methods were similar to those described in detail 
elsewhere [12, 13]. Briefly, the concentric-style dialysis probe had an outside diameter 
of 250 pm, a 4 mm-long tip and was perfused with Ringers (128.3 mM NaCI, 2.68 
mM KC1, 1.35 mM CaCI2, 2.0 mM MgCI2, pH 7.3) at 1.5/~l/min. Samples were col~ 
lected over 20 min intervals. Dialysate was analyzed within 20 rain after collection 
for DA, dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA) and 5-hy- 
droxy-indoleacetic acid (5-HIAA) by high performance liquid chromatography 
(HPLC), with series oxidative-reductive electrochemical detection using flow- 
through 'coulometric' electrodes (ESA, Bedford, MA). All probes were tested for 
recovery in vitro at 37°C prior to implantation, and dialysate values are corrected 
for probe recovery. 
Methamphetamine pretreatment caused a large depletion of DA and serotonin 
(5-HT) in postmortem tissue, as expected [9]. For example, the postmortem tissue 
concentration of striatal DA in methamphetamine-pretreated rats (mean + S.E.M., 
2.7 ± 0.59 ng/mg wet tissue wt.) was only 18.5% of that in saline-pretreated controls 
(14.51 +_ 1.06). The postmortem tissue concentration of DA in the nucleus accumbens 
was less affected by methamphetamine pretreatment, with the concentration in meth- 
amphetamine-pretreated rats (5.97_+0.49) being 50.9% of control (ll.73_+0.68). 
5-HT was also greatly depleted by methamphetamine. For example, in the medial 
frontal cortex of methamphetamine-pretreated rats 5-HT was 0.143_+0.04 ng/mg, 
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Fig. 1, The average (_+ S.E.M.) extracellular concentrations (fmol/min; corrected for probe recovery) of 
dopamine, dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA) and 5-hydroxyindoleacetic 
acid (5-HIAA) estimated by microdialysis during baseline (B) and for ten 20 min intervals after a challenge 
injection of 1.5 mg/kg of (+)-amphetamine. Rats were pretreated with either methamphetamine (solid 
symbols; n = 5) or saline (open symbols; n = 7). S.E.M. bars are not shown for dopamine because they 
are overlapping at all points of time. Dopamine: a two-way ANOVA with repeated measures resulted in 
no significant effect of group, a highly significant effect of time, and a significant group by time interaction 
(F=2.69, P<0.008). However, the two groups did not differ significantly at any single point in time, 
including baseline (individual t-tests). DOPAC: two-way ANOVA, effect of group (F=22.1, P<0.001), 
time (F= 56.1, P < 0.001) and group-by-time interaction (F= 14.5, P < 0.001). The two groups differed at 
all points in time (individual t-tests). HVA: effect of group (F= 9.82, P < 0.01), time (F= 28.8, P < 0.001) 
and group-by-time interaction (F= 12.0, P<0.001). The groups differed at all points in time except 
between 60 and 100 min after (+)-amphetamine (individual t-tests). 5-HIAA: effect of group (F= 23.8, 
P<0.001), time (F=8.85, P<0.001) and group-by-time interaction (F= 1.95, P<0.05). The groups dif- 
fered at all points in time (individual t-tests). 
Despite the deplet ion of  striatal D A  in pos tmor tem tissue, me thamphe tamine  pre- 
t reatment  had no effect on the extracellular concent ra t ion  of  striatal D A  under  rest- 
ing condi t ions  (20.22 _+ 5.9 and 18.69__ 3.6 fmol /min  in me thamphe tamine  vs saline- 
pretreated rats, respectively). In  contrast ,  me thamphe tamine  pre t rea tment  depleted 
resting extracellular D O P A C ,  HVA and  5 -HIAA by 63.5%, 61.9% and  75%, respecti- 
vely, relative to saline-pretreated animals  (Fig. 1). 
The challenge inject ion of ( + ) - a m p h e t a m i n e  produced a large increase in the 
extracellular concent ra t ion  of  DA in both control  and  methamphetamine-pre t rea ted  
196 
animals (Fig. 1). Al though methamphetamine-pret reated rats showed a somewhat  
at tenuated initial response to the (+ ) - a m phe t a m ine  challenge, this tendency was not 
quite statistically significant. ( + ) - A m p h e t a m i n e  produced a significant decrease in 
the extracellular concentra t ion o f  D O P A C  and H V A  in both  methamphetamine-  and 
saline-pretreated animals, and large differences between the groups were evident at 
all points in time (Fig. 1). The effect o f  (+ ) - a m phe t amine  on extracellular 5 -HIAA 
was much smaller, but it did produce a significant gradual elevation in extracellular 
5 -HIAA in both groups, and both groups differed greatly at all points in time (Fig. 1). 
Fig. 2 illustrates the effect of  an acute injection o f  ( + ) - amphe tamine  on moto r  ac- 
tivity, and for ease o f  comparison,  the effect o f  ( + )-amphetamine on the extracellular 
concentrat ion of  DA is replotted f rom Fig. 1 as an overlay. In control  animals 
( + )-amphetamine produced a typical increase in moto r  activity, which peaked about  
60 min after the injection and then slowly subsided to baseline levels. ( + ) - A m p h e t a -  
mine produced a significantly more robust  behavioral response in methampheta-  
mine-pretreated animals than in controls.  The onset o f  hyperactivity was more rapid 
and pronounced  in methamphetamine-pret reated animals, and they were signifi- 
cantly more active than the controls  for the first 40 min after the d-amphetamine 
challenge (Fig. 2). 
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Fig. 2. The effect of a challenge injection of (+)-amphetamine on motor activity expressed as the average 
(_+ S.E.M.) number of 90 ° turning movements (bar graph) during a 20 min baseline period (B) and each 
of ten 20 min intervals following the amphetamine challenge. Rats were pretreated with either methamphe- 
tamine (shaded bars; n=4) or saline (open bars; n=9). Behavioral data were lost for one methampheta- 
mine-pretreated rat and only behavioral data were obtained for two additional saline-pretreated rats. The 
average extracellular concentration of DA is replotted from Fig. 1 as an overlay for ease in comparing 
the behavioral and neurochemical data (solid symbols, methamphetamine-pretreated; open symbols, 
saline-pretreated). Behavior: two-way ANOVA, effect of group (F= 3.03, not significant), time (F= 11.9. 
P < 0.001) and group-by-time interaction (F= 4.4, P < 0.001). The asterisks indicate that the groups dif- 
fered significantly (P < 0.05) during the first two 20 rain intervals after (+)-amphetamine administration. 
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In summary, repeated high doses of methamphetamine produced a persistent (at 
least 1 week) depletion of DA in postmortem tissue obtained from the striatum, and 
DA concentrations have been shown to accurately reflect DA terminal density fol- 
lowing a lesion [2]. This lesion was not accompanied by a significant decrease in the 
basal extracellular concentration of  DA estimated by microdialysis, and furthermore, 
methamphetamine-pretreated animals showed a relatively normal increase in extra- 
cellular DA in response to a (+)-amphetamine challenge. These data suggest that 
the sparing of  function (i.e. absence of  behavioral deficits) seen after neurotoxic doses 
of methamphetamine may be due to presynaptic compensatory changes in the 
remaining population of DA terminals that serve to 'normalize' the extracellular (and 
presumably synaptic) concentration of DA. 
The presynaptic compensatory changes responsible for the normalization of extra- 
cellular DA after a partial lesion have not been fully characterized, but there are a 
number of changes that have been identified and probably interact to produce the 
final effect. For example, the rate of  DA synthesis in the remaining terminals is 
known to greatly increase [17], and the discharge rate in the remaining DA cells in- 
creases [8]. This latter observation is presumably related to increased DA release 
from the residual DA terminals [15]. The lesion also destroys DA reuptake sites, and 
therefore, DA can diffuse much farther through the extracellular space in animals 
with a lesion than in intact animals. 
It is interesting to compare the effects of  (+)-amphetamine on extracellular DA 
and behavior (Fig. 2). The challenge injection of (+)-amphetamine produced a simi- 
lar increase in the extracellular concentration of DA in methamphetamine- and 
saline-pretreated rats, but a much larger initial behavioral response in the metham- 
phetamine-pretreated animals. It is not clear what is responsible for the behavioral 
effect, but it seems to be a reliable phenomenon because it has been also reported 
in mice given neurotoxic doses of methamphetamine [16]. Striatal DA receptor super- 
sensitivity could be involved, but this does not develop until striatal DA is depleted 
by over 80-85% [15]. Another interesting possibility is that the enhanced behavioral 
response reflects sensitization in the nucleus accumbens. Prior amphetamine treat- 
ment is known to produce an increase in the motor stimulant effects induced by a 
subsequent amphetamine challenge [11], and this behavioral sensitization is accompa- 
nied by enhanced DA release in the nucleus accumbens [12]. Methamphetamine pre- 
treatment did not deplete DA in the nucleus accumbens to the same extent as in the 
striatum [9], and therefore, the robust behavioral response to (+)-amphetamine may 
reflect sensitized DA release in the relatively intact nucleus accumbens. 
Supported by NIDA Grant  04294 and a RCDA (NS00844) to T.E.R. We thank 
Laura Levy and Lori Ruddock for assistance in conducting the experiments. 
1 Altar, C.A. and Marien, M.R., Preservation of dopamine release in the denervated striatum, Neurosci. 
Lett., 96 (1989) 329-334. 
2 Altar, C.A., Marien, M.R. and Marshall, J.F., Time course of adaptations in dopamine biosynthesis, 
198 
metabolism, and release following nigrostriatal lesions: implications for behavioral recovery from 
brain injury, J. Neurochem., 48 (1987) 39(~399. 
3 Ando, K., Johanson, C.E. and Schuster, C.R., Effects of dopaminergic agents on eye tracking before 
and after repeated methamphetamine, Pharmacol. Biochem. Behav., 24 (1986) 693 699. 
4 Ando, K., Johanson, C.E., Seiden, L.S. and Schuster, C.R., Sensitivity changes to dopaminergic agents 
in fine motor control of rhesus monkeys after repeated methamphetamine administration, Pharmacol. 
Biochem. Behav., 22 (1985) 737 743. 
5 Bittner, S.E., Wagner, G.C., Aigner, T.G. and Seiden, L.S., Effects of a high-dose treatment of meth- 
amphetamine on caudate dopamine and anorexia in rats, Pharmacol. Biochem. Behav., 14 (1981) 
481 486. 
6 Castafieda, E., Whishaw, I.Q. and Robinson, T.E., Changes in extracellular dopamine concentrations 
measured by in vivo intracerebral dialysis after dopamine depletion, Soc. Neurosci. Abstr., 15 (1989) 
559. 
7 De Vito, M.J. and Wagner, G.C., Functional consequences following methamphetamine-induced 
neuronal damage, Psychopharmacology, 97 (1989) 432 435. 
8 Hollerman, J.R. and Grace, A.A., Nigral DA cell recruitment as a compensatory mechanism, Soc. 
Neurosci. Abstr., 14 (1988) 1146. 
9 Morgan, M.E. and Gibb, J.W., Short-term and long-term effects of methamphetamine on biogenic 
amine metabolism in extra-striatal dopaminergic nuclei, Neuropharmacology, 19 (1980) 989 995. 
l0 Ricaurte, G.A., Schuster, C.R. and Seiden, L.S., Long-term effects of repeated methylamphetamine 
administration on dopamine and serotonin neurons in the rat brain: a regional study, Brain Res., 193 
(1980) 153-163. 
11 Robinson, T.E. and Becker, .I.B., Enduring changes in brain and behavior produced by chronic amphe- 
tamine administration: a review and evaluation of animal models of amphetamine psychosis, Brain 
Res. Rev., 396(1986) 157 198. 
12 Robinson, T.E., Jurson, P.A., Bennett, J.A. and Bentgen, K.M., Peristent sensitization of dopamine 
neurotransmission in ventral striatum (nucleus accumbens) produced by past experience with 
( + )-amphetamine: a dialysis study in freely moving rat, Brain Res., 462 (1988) 211 222. 
13 Robinson, T.E. and Whishaw, I.Q., Normalization of extracellutar dopamine in striatum following 
recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in free- 
ly moving rat, Brain Res., 450 (1988) 209 224. 
14 Seiden, L.S. and Ricaurte, G.A., Neurotoxicity of methamphetamine and related drugs. In H.Y. 
Melzer (Eds.), Psychopharmacology: The Third Generation of Progress, Raven, New York, 1987, pp. 
359 366. 
15 Stricker, E.M. and Zigmond, M.J., Brain monoamines, homeostasis, and adaptive behavior. In: Hand- 
book of Physiology, Vol. 4, Intrinsic Regulatory Systems of the Brain, American Physiological Society, 
Bethesda, MD, 1986, pp. 677 698. 
16 Yamanaka, Y., Takano, R. and Egashira, T., Methamphetamine-induced behavioral alterations fol- 
lowing repeated administration of methamphetamine, Jpn. J. Pharmacol., 41 (1986) 147 154. 
17 Zigmond, M.J., Acheson, A.L., Stachowiak, M.K. and Stricker, E.M., Neurochemical compensation 
after nigrostriatal bundle injury in an animal model of preclinical parkinsonism, Arch. Neurol., 41 
(1984) 856 861. 
